Korea's new drugs advancing into 2005 output of 100 finished items
Published: 2006-06-29 06:57:00
Updated: 2006-06-29 06:57:00
Domestically developed new drugs Dong's Stillen capsule, SK's Joins tablet, and Yuyu's Maxmarvil tablet ranked in 2005 output of Korea's top 100 finished drugs, according to data released by the Korea Pharmaceutical Manufacturers Association.
Stillen capsule and tablet ranked 43rd and 66th w...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
